Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Denver news in your inbox
Catch up on the most important stories affecting your hometown with Axios Denver
Des Moines news in your inbox
Catch up on the most important stories affecting your hometown with Axios Des Moines
Minneapolis-St. Paul news in your inbox
Catch up on the most important stories affecting your hometown with Axios Twin Cities
Tampa Bay news in your inbox
Catch up on the most important stories affecting your hometown with Axios Tampa Bay
Charlotte news in your inbox
Catch up on the most important stories affecting your hometown with Axios Charlotte
Carl Icahn is backing down. Photo: Adam Jeffery/CNBC/NBCU Photo Bank via Getty Images
Billionaire investor Carl Icahn will no longer try to get shareholders to vote against Cigna's pending takeover of Express Scripts.
Why it matters: So much for that brief spat. Icahn didn't think the battle was worth fighting any more after the two major proxy advisory firms recommended shareholders approve the deal. Icahn's retreat makes it a lot more likely investors will vote for the acquisition, but federal and state antitrust reviews are still pending.